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Abstract 
LONG-TERM EFFECTS OF NOTCH1 SIGNALING ON REGENERATIVE NEURAL STEM 
CELLS IN RESPONSE TO TRAUMATIC BRAIN INJURY 
By:  
Cruz Sevilla Jr. 
A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science 
at Virginia Commonwealth University 
Virginia Commonwealth University, 2019 
Advisor: Dong Sun, MD, PhD 
Traumatic brain injury (TBI) is a devastating problem which stands as a leading cause of 
death and disability. The elderly is significantly affected by TBI, typically as the result of falls, 
and recovery is especially limited. This, in part, is associated with decreased tissue-specific stem 
cell regeneration and replacement of damaged cells in the aged brain. The diminished ability of 
the aged brain to recover is especially devastating after TBI, likely leading to permanent loss of 
sensory, motor, and cognitive functions. Studies have shown that the mature mammalian brain 
contains Neural Stem Cells (NSCs), found in specific regions of the brain, which can generate 
functional neurons during normal and pathological conditions. Two of those regions, the 
Dentate Gyrus (DG) of the hippocampus as well as the Subventricular Zone (SVZ) of the lateral 
ventricles, have proven to be niches for these multipotent NSCs. A key regulator in the 
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maintenance of these NSCs is the Notch signaling pathway, shown to control proliferation, 
differentiation, and apoptosis of NSCs during development and throughout adulthood. In the 
current study, we assessed the regulatory mechanisms that drive the regenerative functions of 
NSCs in a neuropathological state following TBI. Using the Lateral Fluid Percussion Injury model, 
we analyzed the diffuse effects of the injury response on 3-month old male Sprague-Dawley 
rats. Immediately following TBI, Notch agonist, antagonist or vehicle was infused into the lateral 
ventricle for 7 days to assess the role of Notch signaling on neural stem cell 
proliferation/survival and neurogenesis at 30 days post-TBI. Dividing cells during infusion time 
were labeled with BrdU via single daily intraperitoneal injections for 7 days.  Animals were 
sacrificed at 30 days post-injury and brain tissues were processed then immunolabeling for 
BrdU and Doublecortin. We found a higher number of BrdU-positive cells in the FPI+Notch1 
agonist group when compared to Sham and FPI+Jagged-1 Fc antagonist groups in the 
contralateral granular zone. A significant increase in proliferation/survival was also seen in 
FPI+Notch1 versus Sham/FPI+Jagged-1 Fc and for FPI+Vehicle versus Sham animals in both the 
ipsilateral and contralateral hilus. DCX immunolabeling did not establish a significant difference 
in FPI+Notch1 compared to Sham animals, nor across any other groups, which is consistent with 
what we know of activation of the Notch pathway. Our results demonstrate that Notch1 
signaling is directly involved in cellular proliferation/survival of NSCs in the DG following TBI at 
30 days post-injury, but further work must be done to understand the fate of these cells. Thus, 
drug treatment targeting Notch1 signaling could serve as a potential therapeutic target 
following TBI to preserve NSCs and limit long-term cognitive deficits.  
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Chapter 1 – Introduction 
Traumatic Brain Injury – Epidemiology  
Traumatic brain injury (TBI) is a devastating problem that stands as a leading cause of death 
and disability. The World Health Organization recognizes neurotrauma as a critical health 
problem often leading to permanent health consequences. Due to the variety of ways it can 
occur, neurotrauma stands as a difficult health issue to address. Within the last decade, there 
has been a considerable shift in focus on TBI, in part due to advancements in technology 
capable of identifying this problem. Vehicle accidents, military combat, accidents at home, and 
helmet-to-helmet contact as seen in the NFL have helped draw warranted attention to assess 
ways to prevent and respond to neurotrauma.1,2 In addition, research is actively highlighting 
differences in the types of TBI, either acute or chronic in nature, to better understand how to 
deal with specific instances of injury.2 Specifically, analysis of different biomarkers often seen in 
the normal inflammatory process has helped to aid in diagnosis and prognosis of TBI. 
In addition to the breadth of examples that lead to neurotrauma, there is as wide a 
spectrum of ages of victims who are at risk or have been reported to suffer from this type of 
injury. 3–5 Children, adults, and the elderly are all susceptible to lasting physical and intellectual 
impairments caused by neurotrauma. Pediatric TBI is considered a chronic condition due to 
long-term cognitive and psychosocial deficits suffers, as survivors of injury get older. 4 Adults, 
and more specifically athletes, have received highlighted attention to the effects of 
concussions. One study of former professional athletes demonstrated that the number of 
sports-related concussions served as a predictor for a number of common mental disorders, 
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such as anxiety, depression, and sleep disturbances, 6 while others have compared post-
mortem, concussed brains to those of Alzheimer’s patients. 7 If a patient is fortunate to survive 
from TBI, they will likely endure large economic costs as a result of the necessary long-term 
care.1 The elderly is not only extremely susceptible to TBI, but can suffer worse consequences. 
A study comparing different aged group mortality rates 6 months post-injury demonstrated 
that the group of 64-year-olds and older had more than twice the mortality rate of the younger 
group, aged 20 to 40-years-old. This was in spite of the younger group having a more severe 
mechanism of injury than the older group.3 Other studies have confirmed and furthered the 
correlation of increasing age and increasing mortality rates 8,9 in the elderly and greater 
functional decline when compared against younger groups. 10 Within the United States, the 
number of people age 65 or older was roughly 48 million in 2015, making up 15% of the total 
population, according to the World Health Organization. By the year 2060, that population is 
expected to more than double to 98.2 million individuals. People are expected to live longer 
thanks to advancements in modern medicine; however, implications of an aging body, such as 
pre-existing health conditions, make understanding neurotrauma all the more imperative. 11 
As studies begin to dissect the varying degrees of neurotrauma, more can be understood 
about how it works and how to treat it. Analysis of different pro-/anti-inflammatory agents 
across the Central and Peripheral Nervous system 2 demonstrate the range of 
neuroinflammatory responses that are triggered by TBI. Study of specific genes, such as brain-
derived neurotrophic factor (BDNF), 12 highlight the importance of understanding genetic 
factors and their products that play a role in TBI-related issues.  
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Our lab has spent the last few years analyzing different aspects of neurotrauma. With a 
primary focus on TBI, we discovered valuable information about how the brain responds to 
injury. 13,14 The work we have done, as well as work completed by others, primarily focus on 
animal models to study these injuries. Short-term consequences of TBI have illuminated 
mechanisms involved; however, questions about the long-term effects remain.  
 
Biomechanics and Mechanisms of TBI 
 Traumatic brain injury occurs as the result of an external force acting and altering brain 
function. 15 Instances of TBI are plentiful; as are signs required for classification: loss of 
consciousness or memory, disorientation, or loss of balance to name a few. Physical injury 
fundamentally shifts the normal mechanisms of the brain to varying degrees, depending on the 
type and severity of injury. In the realm of TBI, damage incurred leads to both primary and 
secondary injuries. Primary injury is the injury sustained during the traumatic event, often as 
the result of falls or mechanical insults. Damage resulting from primary injury includes neuronal 
cell death, subdural and epidural hematomas, and vascular damage.16  Secondary injury 
damage can accrue from hours to days  after the initial injury and is characterized by metabolic 
and cellular changes in the brain. 15  
Intracranial damage has been classified in two separate categories: diffuse and focal. As 
the name implies, diffuse injury to the brain is frequently widespread. Diffuse axonal injury 
(DAI), is a common example of brain injury that results in damage to white matter in the brain. 
Focal injuries, in general, involve a pin-pointed focus on certain regions of the brain. These 
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injury types have been broken down to further clarify and understand the post-traumatic 
processes following TBI. For example, a proteomic study differentiating the two types of injury 
in human brain tissue showed increase expression of peptides related to neurodegeneration 
and decreased expression related to antioxidant defense in diffuse TBI patients versus those 
suffering focal injuries. 17 This point exemplifies the complexity associated with TBI and why a 
thorough understanding of the mechanics is so important.  
 Differences in injury types for TBI have been demonstrated experimentally in rodents to 
better understand ways TBI can be treated.18,19 For example, many studies, including those 
done by our lab, utilize fluid percussion injury (FPI) models to replicate clinical TBI without 
fracturing the skull.13,20 Lateral FPI model results in damage directly at the point of fluid impact 
and diffuse injuries in brain regions far from the impact, whereas midline FPI induces more 
diffuse injury  As its severity increases, this type of FPI can lead to changes in behavior. 21 Other 
models, such as controlled cortical impact (CCI) 22 and acceleration-impact injury models 
causing a focal injury are widely used models  as well. 23 The overlap between rodent and 
human injury mechanisms makes it useful for the potential development of therapeutic 
methods for TBI. It is our hope that deeper understanding of these processes will lead to better 
long-term care for individuals with TBI.  
 
TBI: Long-Term Consequences 
 According to the CDC, over 2 million people are thought to be affected each year by 
TBI.24 When the brain is physically damaged, the results are not only long-lasting and complex, 
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but costly as well. Estimates of lifetime costs for those suffering TBI span in the millions of 
dollars for victims. 1 Besides the immediate damage that results, patients are also subjected to 
secondary neurological issues such as personality disorders 25, and chronic pain and 
headaches.24 Some studies have demonstrated a connection to patients developing psychosis 
and schizophrenia 26, while others have even linked the offspring of parents who have suffered 
a TBI to more frequently utilize psychiatric care facilities. 27 Another commonly associated issue 
following TBI is major depression in patients. 28  
 
Adult Neurogenesis 
The idea of “adult neurogenesis” was previously thought to be somewhat of an 
oxymoron until the mid-1960’s, when a duo of scientists uncovered a proliferative region of the 
rat brain: the hippocampus; although, Joseph Altman is recognized as the first to discover the 
neurogenic potential of cells within the hippocampus.29 He posited that postnatally, there exists 
an “undifferentiated” pool of cells that gradually declines in number, resulting in a 
corresponding increase in differentiated granule cells. This idea sparked so much of what we 
understand about neurogenesis today. Mammalian studies centering around neurogenesis 
have solidified the idea first posited by half-a-century ago that a pool of multipotent stem cells 
exists after development, lasting through adult life.30,31 In humans, studies done in postmortem 
tissue  determined the existence of stem cells within the same regions identified in rodent 
studies.32 Of course, humans and rat development and maturation processes are not exactly 
equal, but have been reviewed and compared showing enough similarity to demonstrate the 
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value in understanding the mechanisms of the latter to gain insight on the former. 33 Due to 
restrictions and ethical issues in studying developing human tissue, rat and mouse models are 
used to investigate the mechanisms that make up this process. Scientists are actively comparing 
developmental neurogenesis and that seen throughout adult life. 34  
Neural Stem Cells (NSCs) are a recently uncovered tool of significant importance in brain 
development, maturation, and recovery. Residing within specific regions of the brain, the NSCs 
are a class of self-renewing cells with the capacity to generate new neurons and other cell types 
within the nervous system. These regions, often referred to as the neurogenic niches of the 
brain, are capable of sustaining proliferation and differentiation from the preexisting pool of 
stem cells.  Today, it is well understood that those two regions include the dentate gyrus (DG) 
of the hippocampus and the subventricular zone (SVZ) of the lateral ventricles. 13,29,30,35–37 Stem 
cells from each specific region have their own capacity to differentiate. For example, in vivo 
progenitor cells that come from the SVZ of the lateral ventricles have a specific path of 
migration towards the olfactory bulb. These cells travel along what is known as the rostral 
migratory stream (RMS) and will potentially become mature olfactory neurons.30 Studies have 
shown cells of the SVZ will also become olfactory interneurons vital for olfactory discrimination, 
sensitivity, memory and specificity.38 In all, these cells relay sensory information to the olfactory 
cortex and serve a vital role in odor processing.38,39 Structurally, rodents have a relatively larger 
volume of the olfactory bulb in comparison to humans, which has made analysis of the SVZ 
both common and useful.  
In both rodents and humans, the stem cells residing within DG of the hippocampus play 
a different role than those in the SVZ. Studies have demonstrated the NSCs of the DG to have a 
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significant role in learning, memory, and cognitive function. 36,40 Cells residing within the DG can 
become excitatory granule cells whose axons form the mossy fiber tract.40 This tract connects 
the DG to the CA3 region of the hippocampus. The dentate gyrus (Figure 1.1) has been broken 
down further into subregions, including the molecular layer (MOL), the granular cell layer (GCL), 
and the hilus or polymorphic layer. The granular layer, often referred to as the granular zone, 
consists of a subregion called the subgranular zone (SGZ) which is now known to be the site of 
origin of stem cells. Cells within the SGZ can travel through the granular cell layer toward the 
molecular layer as they differentiate. 41 While the final location differs for stem cells within the 
different neurogenic niches, both processes have been determined to be controlled in part by 
molecules in the extracellular matrix and ligands found on other cells.42 
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Figure 1.1 The Dentate Gyrus of the Hippocampus. Image extracted from Scharfman 2016. (A) 
Depicts a breakdown of the layers of the dentate gyrus DG of the hippocampus. The molecular 
layer, the granular layer, and the hilus are all pictured. (B) Demonstrates a coronal section of 
the same DG structures. 
 
 
 
 
(A) (B) 
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Stem cells progress through different phases (Figure 1.2) as they mature. In general, 
NSCs will differentiate to neural progenitor cells (NPCs) before becoming mature neurons. A 
thorough background of adult hippocampal neurogenesis has been established, exposing 
distinct phases and corresponding cell types.35 These phases are triggered by specific signals 
and as the cells progress through the stages and can be classified by differences in morphology. 
The first stage of neurogenesis consists of Neural Stem Cells (NSCs), which differentiate into 
Type 1 Neural Progenitor Cells (NPCs). The latter cell type then differentiates into a Type 2 NPC 
before differentiating further into a Neuroblast. 34  
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Figure 1.2 Differentiation of NSC’s in the DG. Image extracted from Kempermann et al., 
2015. This visual represents the progression of neurogenesis through various phases, from NPC 
to a mature neuron. Additionally, stage-specific markers are noted on the right.  
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While studies have demonstrated differences within the makeup of young/mature NSCs, 
the overarching view of adult neurogenesis has been one of a continuation of development.34  
This has made the understanding and investigation of the developmental process key to 
providing insight on how the adult brain functions. Neural stem cells are also known to be an 
active component of regenerative processes, as well as homeostatic conditions. Character traits 
of stem cells have allowed for manipulation of growth to better understand the proliferation 
process. One study identified a certain type of stem cell within the SVZ to contain epidermal 
growth factor receptor (EGFR). When presented with EGF, this receptor signals for proliferation 
of the NSC. 43 Knowledge of the intrinsic properties of stem cells has allowed for comparisons in 
other drug treatment studies, such as these experiments. Although there is an overlap in the 
developmental process and adult neurogenesis, there exists a difference in the responsiveness 
of tissue that is aged dependent. Dr. Sun et. al, completed work that demonstrated specifically 
how aged tissue is worse at recovering from TBI than its younger counterpart. Specifically, we 
demonstrated that aged tissue has a higher apoptotic response and reduced levels of 
proliferation within the DG of the hippocampus. 14,44  There exists an age-related decline of a 
tissue’s capacity, which is due to NSC’s gradual decline in potency. Further, there is an age-
related impairment of hippocampal cognition found in both humans and primates.33 
Interestingly, the result of reduced neurogenesis in aging tissue does not occur from loss of 
NSCs, but rather a transition of the stem cells from a potent-to-quiescent state.45 This was 
demonstrated via a correlation between a loss of active horizontal NSCs in aged mice, rather 
than a decrease in quantity of the observed NSCs. Establishing an understanding of how aging 
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tissue behaves can further aid in the process of treating both the elderly population, as well as 
those who suffer neurotrauma.    
Notch Signaling Pathway 
Current research has begun to unveil the mechanisms in which NSCs function. The Notch 
Pathway has been implicated as a key regulator in neurogenesis. 46–48 Our lab and others have 
begun mapping the downstream effects of Notch activation and demonstrating its role on for 
NSCs. Notch is thought to be critical for NSC maintenance and differentiation as well as learning 
and memory.49 Serving as a regulator for the timing of motor neuron genesis as well as 
maintaining the progenitors in a proliferative state under homeostatic conditions50, the role 
and importance of Notch is likely to carry over into recovery following neurotrauma.  
The pathway is a simple, well preserved process which is associated with other well studied 
regulatory mechanisms in tissues that undergo neurogenesis, hematopoiesis, and more.51,52 
Through interactions with exposed ligands, such as Jagged 1/2 and Delta-like ligands 1/3/4, 
from neighboring cells, the Notch receptor itself is cleaved via gamma-secretase, resulting in 
the release of the Notch intracellular domain (NICD) Figure 1.3. This portion will then 
translocate into the nucleus and interacts with a class of proteins in humans known as CSL 
(CBF1, Suppressor of Hairless, and Lag-1). These proteins act as transcriptional activators, 
producing a series of products dependent on the type of Notch receptor activated. Although 
there are several different Notch receptors which have been discovered, it appears that Notch 
2/3 have similar, repetitive functions.53 Commonly seen products are Hes1/Hes5, or hairy and 
enhancer of split family.52  Hes genes have been demonstrated to be important for 
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transcriptional repression in one study of a loss-of-function hematopoietic stem cell line.52 In 
the nervous system, experiments have shown that Hes is vital for maintaining the pool of neural 
stem cells by inhibiting neuronal transcriptional effectors (Neurogenin/Mash1).48 A knockout 
study done in mice demonstrated that upregulation of Hes1 resulted in differentiation of NPCs, 
while its downregulation caused the opposite effect. 54  In a simplified sense, Notch signaling 
products act on the existing pools of NSCs to prevent differentiation and thereby maintaining 
them in their proliferative state. Current studies have helped understand the role of Notch on 
NSCs during development and adult maturation. What remains unclear, however, is the extent 
that Notch plays in recovery following TBI. 
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Figure 1.3 The Notch Signaling Pathway. Image extracted from Yoon et al., 2005.55 Notch 
receptor activation requires an extracellular protein from another cell to trigger the signaling 
cascade. ɣ-secretase cleaves a portion of the Notch receptor, the NICD, which translocates into 
the nucleus, resulting in transcription of genes like Hes.  
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TBI-induced neurogenesis (TBI and the Notch pathway) 
Animal models are currently the most popular options to replicate TBI because of 
standardized outcome measurements, low costs, and other factors, although some studies 
have utilized larger animals.18 In Dong Sun’s lab, work has been completed to establish the 
neurogenic niches in the adult brain and to demonstrate that Notch signaling is a key regulatory 
mechanism which mediates regenerative NSC response post-TBI.56 Increased levels of Notch-
specific proteins were also observed within the SVZ of a 3-month TBI rat. It was noticed that in 
comparing the levels of those same proteins in aged versus young rats, the levels were 
markedly lower in the former.14 Generally, the older the tissue becomes, the worse it becomes 
at recovery. Within the nervous system, when compared to younger tissue, aged tissue is 
associated with decreased tissue-specific stem cell regeneration and replacement of damaged 
cells56. Thus, this aging-related character of tissue compounded with TBI frequently results in 
permanent loss of sensory, motor, and cognitive functions as the result of brain injury.   
 Presently, there is little-to-no knowledge available about the role of Notch following TBI; 
however, we speculate that Notch could likely play a role in regulating TBI-induced NSC 
regulation based on its role in development. 
 
Hypothesis 
Our focus in this study was to analyze the longer-term effect of Notch signaling on 
neurogenesis following traumatic brain injury. By manipulating the Notch signaling pathway 
through administering Notch agonist (Notch1 antibody) or Notch antagonist (Jagged1 Fusion 
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protein), we set out to assess how NSCs from the neurogenic niches would respond following a 
moderate TBI. With our previous work as a foundation, we expanded upon a 7-day study that 
involved administration of the same drug treatment groups to determine the difference at 30 
DPI. We hypothesized that increased activity of the Notch signaling pathway through the 
Notch1 antibody would result in increased proliferation/survival and decreased differentiation 
of NSCs within the DG. Contrarily, we expected inhibition of the same pathway to result in 
decreased proliferation and increased differentiation of stem cells in the hippocampus.  
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Chapter 2 – Materials and Methods 
Experimental animals 
The focus of this experiment is to determine the effects of Notch Signaling on long-term 
endogenous neural stem cell proliferation, survival and differentiation in the dentate gyrus of 
the hippocampus following traumatic brain injury. Adult rats were exposed to a moderate 
traumatic brain injury, followed by an intraventricular administration of a Notch agonist 
(Notch1), Notch antagonist (Jagged-1 Fc), or Vehicle infusion for 7-days via osmotic minipump. 
A total of n=21, male, 3-month old Sprague-Dawley rats (ENVIGO Corporation) were utilized. 
Weighing roughly 300 grams, the rats were provided food and water ad libitum while housed in 
pairs in a Plexiglas cage on a 12-hour light cycle. Procedures and handling followed the ethical 
care guidelines and were approved by the Institution of Animal Care and Use Committee 
(IACUC) of Virginia Commonwealth University, the Guide for Care and Use of Laboratory 
Animals and by the U.S. Department of Health and Human Services.  
 
Experiment Setup 
 Animals were randomly separated into four groups. Three of those four groups were 
exposed to traumatic brain injury (TBI) and were further separated based on drug treatment. 
All animals received the same care and housing. Group one, the Sham group, was composed of 
five animals, did not receive TBI, but was exposed to the same surgical procedures as the other 
groups. Sham group did not receive any drug treatment. Group two, the Vehicle group, had five 
animals, underwent surgery, and received artificial CSF (aCSF) infusion for 7 days-post-injury. 
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Group three, the Notch antagonist group, had five animals, underwent surgery, and was infused 
with Jagged-1 Fc for 7 DPI. Group four, the Notch agonist group, had six animals, underwent 
surgery, and received the Notch agonist infusion for 7 DPI. Each group of animals was given 
single, daily intraperitoneal injections of 50 mg/kg BrdU for 7 DPI. All animals were sacrificed at 
30 days-post-injury (DPI).   
Table 2.1 Animal Grouping 
 N= Injury Drug Treatment Dosage 
Group 1 - Sham 5 No No N/A 
Group 2 – FPI + Vehicle 5 LFPI Yes, aCSF (Vehicle) 100ul 
Group 3 – FPI+ Jagged-1 
(Notch antagonist) 
5 LFPI Yes, human recombinant 
Jagged-1 fusion protein 
50µg/mL 
Group 4 – FPI + Notch1 
(Notch agonist) 
6 LFPI Yes, Notch1 antibody 2µg/mL 
 
Table 2.1 Animal Grouping. Animals were split into 4 groups. Group 1 was the only group not 
exposed to a Lateral Fluid Percussion Injury (LFPI) or drug treatment. Group 2, 3, and 4 all were 
subjected to Lateral Fluid Percussion Injury and received Vehicle (aCSF), Notch1 antagonist 
(Jagged-1 Fc) and Notch1 agonist (Notch1 antibody) infusions for 7 days, respectively. All 
groups were given intraperitoneal injections of BrdU at 50mg/kg of body weight for 7 days 
post-injury.  
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Surgical procedures 
Animal groups were dividedly at random to undergo LFPI or Sham injury. Sterilization of 
all surgical instruments was complete prior to surgery. During surgery, aseptic procedures were 
followed through completion to minimize risk. All adult rats were individually contained within 
a Plexiglas holding chamber and anesthetized by exposure to 5% isoflurane until unconscious 
and breathing rate significantly slowed. The animal’s head was then shaved to expose an area 
for incision. Next, it was placed within a stereotaxic apparatus which stabilized the position of 
the animal for surgery. Continuous treatment of isoflurane (2.5%) in a 70% Nitrogen and 30% 
Oxygen gas mixture was given through a nose piece to keep the animal anesthetized. To 
sterilize the surgical site along the animal’s head and to prevent the animal’s eyes from drying, 
Betadine and Paralube ointments were applied, respectively. From here, the animal was incised 
along the midline of the skull using a scapula and the skin was retracted on both sides using a 
hemostat. Excess connective tissue was removed using sterilized cotton swabs. This exposed 
the area of the skull for a 5 mm craniotomy to take place. With the lambdoid and sagittal 
sutures as landmarks, the craniotomy was carried out approximately 1.5 mm anterior to 
lambdoid suture and 2 mm lateral to the midline suture on the left parietal bone using a 
trephine and a Dremel drill. An outline created by the trephine allowed for a clean circular area 
of skull to be removed. If necessary, small shards of bone were carefully removed to create a 
clear exposure to the brain. This area was utilized for placement of the hub cap, which 
connected to the Fluid Percussion injury instrument. In addition, a burr hole was created 
approximately 1.5 mm laterally and 1 mm posteriorly from bregma and was the point for 
implantation of the intraventricular infusion cannula. After implantation of the infusion cannula 
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into the injury ipsilateral side lateral ventricle, the cannula was secured with dental acrylics. The 
cannula connected osmotic min-pump was then embedded subcutaneous at the back of the 
neck. Once surgery was complete, the animal was sutured with a 4-0 monofilament in a running 
locking pattern. Application of lidocaine jelly and a triple antibiotic ointment were generously 
applied to the closed wound and isoflurane treatment ceased. From here, the animal was 
monitored to ensure normal breathing began and continued. Animals were returned to their 
recovery cage and placed over a warming pad. They were observed for 15 to 20 minutes post-
operatively to ensure normal functions returned. The pump was removed at 7 DPI. 
 
Lateral Fluid Percussion Injury 
 Moderate Lateral Fluid Percussion Injury (LFPI) was utilized for this project. Once the 
region of the parietal bone was carefully removed, a hub connector was cemented to the skull 
using cyanoacrylic, then dental acrylic was mixed and applied around the base of the hub and 
allowed to harden. To ensure proper alignment, it was noted that no acrylic leaked within the 
space of the hub and the area was rinsed with 0.9% saline solution with the expectation that 
the solution would not diffuse through the area of exposed brain tissue. Once the safety checks 
were considered, isoflurane was gradually decreased to 1.5% while prepping and testing the 
Fluid Percussion instrument.  To establish a precise administration of a moderate injury within 
the range of 2.05 ± 0.05 ATM, the height of the pendulum was adjusted such that upon release 
and impact, the associated calibration devices displayed an output of the desired pressure. 
Those devices were a pressure transducer amplifier and a Tektronix oscilloscope. Figure 2.1 (A) 
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and (B) display the FPI instrument and calibration devices, respectively.  After appropriate 
pressure readings were measured, the animal was removed off isoflurane until tail reflex was 
back, then connected via the hub to the Fluid Percussion injury instrument. The pendulum was 
released, inducing injury, and the exerted pressure was recorded. Upon injury, a timer was 
started to record the subsequent responses. Once the animal was removed from the device, it 
was immediately placed in a supine position on the table and assessed for breathing.  If a 
respiratory response was not present, manual stimulation was given. Once breathing returned, 
animals were monitored for paw, tail, and righting reflex in that order. An external physical 
stimulus was applied to the animal’s hindlimb and tail until flexion occurred in both. Righting 
time was determined as the time it took the animal to bring itself upright from its side. These 
reflexes have been established to determine completeness of injury. 57  After, the animal was 
brought back to the surgical area and placed back under anesthesia with 5% isoflurane to 
remove the hub and dental acrylic. In addition, a burr hole was created for insertion of the 
infusion cannula for intraventricular drug infusion.  Observing the intersection between the 
coronal and midline sutures allowed for identification of bregma. From the established 0 point, 
the stereotaxic arm was moved 1.5 mm laterally and 1 mm posteriorly to locate the ipsilateral 
ventricle. The depth of the implanted infusion cannula was 3mm from the dura surface. Dental 
acrylic was applied around the base of the cannula to secure it. The connected osmotic mini 
pump was embedded subcutaneously. Finally, the surgical site was closed.  
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Figure 2.1 The LFPI instrument and oscilloscope. (A) Shows the Lateral Fluid Percussion 
Instrument used to deliver injury through a fluid-pulse. (B) Demonstrates a recorded pulse from 
the oscilloscope, which displays a frequency (Hz) based on the current of the fluid flowing 
through the tube. Conversion of Hz to pressure (atm) was calculated after.  
 
 
 
 
 
 
 
(A) (B) 
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Drug Dosage Determination 
The three LFPI groups were separated to receive Vehicle, Notch1 antagonist, or Notch1 
agonist infusions. The 7-day infusion mini-pump contains 100ul of infusion solution. The vehicle 
group was infused with 100ul of aCSF. As previously described by Sun et al. 2010, the 
composition of aCSF consisted of 148mM NaCl, 3mM KCl, 1.4mM CaCl2, 0.8mM MgCl2, 
1.5mMNa2HPO4, and 0.2mMNaH2PO4 at a pH 7.4. The Jagged-1 Fc and Notch-1 groups were 
selected to receive a pre-determined concentration of the selected drug, at 50µg/mL and 
2µg/mL, respectively. These doses were selected based on the dose response study examining 
DG neural stem cell proliferative response following Notch1 agonist and antagonist infusion 
determined previously in our lab.  
 
BrdU Injections  
 To label dividing cells, animals were intraperitoneally injected with bromodeoxyuridine 
(BrdU) at 50 mg/kg body weight, single, daily for 7 days during the infusion period. BrdU is a 
thymine analog, which incorporates into the DNA of all proliferating cells during S-phase. Thus, 
BrdU serves as a crucial indicator of quantity and timing of newly formed DNA/replicating cells 
within the specific timepoint of injury, as seen in previous studies. 20  
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Sacrificing and Tissue Preparation 
At 30 DPI, all animals were sacrificed by transcardic perfusion. Animals were placed in a 
Plexiglass container and deeply anesthetized with an overdose of isoflurane inhalation. A gauze 
pad soaked in isoflurane was used to cover the animal’s facial area to maintain that the animal 
stayed unconscious. An incision was made along the midline of the thoracic cavity, exposing the 
heart. The heart was cross-clamped using rubber tipped hemostats, then a blunt-tip, 16-gauge 
needle was inserted through the left ventricle into the aorta.  Next, the right atrial appendage 
was cut to allow the exit of blood.  A transcardial perfusion was completed, using 150 mL of 
Phosphate-buffered Saline (PBS) and 150 mL of 4% Paraformaldehyde in PBS fixative. PBS 
flowed through the needle, circulating throughout the animal’s vascular system. The flow of 
PBS was continued until the fluid exiting the right atrium was clear and the liver, as well as 
other organs, had lost their dark color. From here, Paraformaldehyde flowed through the 
animal’s circulatory system to serve as a fixative for the tissues. After fixing the tissue, the 
animal was decapitated, and the brain was carefully extracted out from beneath the skull. 
Brains were kept in 4% paraformaldehyde at 4°C until they were sliced. Using a Vibratome 
(Figure 2.2), the brains were sliced coronally into 60 µm slices throughout the ventricles and 
hippocampus. Sequential sections were collected in 4 sets into 24-well plates that were filled 
with PBS and 0.01% sodium azide, then stored in the 4ºC for preservation until further 
processing. Brain sections were used accordingly for immunostaining.  
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Figure 2.2 Tissue slicing and processing. (A) This image captures the Vibratome, used for slicing 
tissue samples. (B) Rat brains were sliced coronally into 60 µm slices throughout the ventricles 
and hippocampus and collected in 24-well plates filled with PBS and 0.01% sodium azide. (C) 
Tissue samples were immunostained and mounted on Superfrost slides, counterstained with 
Crystal Violet, then covered using Permount solution and coverslips. 
 
 
 
(A) (B) 
(C) 
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Immunohistochemistry   
Two separate immunostaining techniques were utilized for this experiment. For each 
brain, 12 sequential sections spanning 480 µm throughout the lateral ventricle and 
hippocampus were selected and were processed for immunostaining of a specific marker. This 
ensured that equal and complete coverage of the hippocampus and ventricles were accounted 
for each animal. Our goal was to identify the presence of BrdU and doublecortin (DCX), an 
immature neuronal marker. The protocol for staining was similar for both markers except the 
DNA denaturing steps for BrdU. Briefly, sections were rinsed in 1X PBS two times for five 
minutes each. For BrdU staining, a denaturing solution composed of 50% formamide, 37.5% 
Nanopure H2O, and 12.5% 20X Sodium Saline Citrate Buffer (SSC) was used. The sections were 
denatured for one hour in an oven set at 65°C. Next, sections were removed from the oven and 
rinsed with 2X SSC for five minutes, two times. After, sections were further denatured in 2N 
Hydrochloric acid (HCl) for 30 minutes in a 37°C oven. Sections were then rinsed again in 1X PBS 
for five minutes, twice.  From the previous step onward, the protocols for BrdU and DCX were 
identical. Following the wash, the trays were quenched in 3% hydrogen peroxide for 1 hour. A 
mixture of 1X PBS with 0.3% Triton X-100 was placed in the trays for 10 minutes. Sections were 
incubated with a blocking buffer, consisting of 5% horse serum in 1X PBS + 0.3% Triton, 
overnight at 4°C. The following day, the blocking buffer was removed, and the specific primary 
antibody solution was prepared: for BrdU, primary monoclonal mouse antibody solution (Life 
Technologies Corp) was set at a dilution of 1:2000 in blocking buffer. For DCX, primary goat anti-
DCX (Santa Cruz Biotech) was made at 1:1000 dilution in blocking buffer. Sections were 
incubated with the primary antibody solution for 48 hours at 4°C on shaker. Sections were then 
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brought back to room temperature and rinsed with 1X PBS + 0.3% Triton for 10 minutes, three 
times. After, they were placed in blocking buffer for 3 hours at room temperature before being 
placed in secondary antibody solutions overnight at 4°C. The secondary antibody solution for 
BrdU was prepared as follows: A Biotin-conjugated anti-mouse antibody, measured at 1:200 
dilution in blocking buffer, from horse (Vector Laboratories, Inc) was prepared. The DCX 
secondary antibody (Vector Laboratories, Inc) solution was anti-goat, biotinylated IgG, prepared 
at 1:200 dilution in blocking buffer. Sections were incubated with the secondary antibody for 
overnight at 4°C on shaker.  On the last day, the sections were brought back to room 
temperature and washed in 1X PBS for 10 minutes, three times. Because our secondary 
antibodies were Biotin-conjugated antibodies, the sections were further incubated with an 
Avidin-Biotin Complex (ABC) solution for two hours at room temperature. This solution works 
by associating with Biotin-conjugated secondary antibody, increasing staining intensity of the 
tissue. The ABC solution was prepared at 1:200 dilution in 1x PBS 30 minutes prior to use. 
Following 2 hours of exposure, the sections were washed with 1X PBS three times for 10 
minutes. Concurrently, DAB solution, consisting of dry diaminobenzidine tetra-hydrochloride 
(DAB) (Sigma) was prepared. With the help of a peroxidase, DAB can be oxidized in the 
presence of hydrogen peroxide, forming a brown precipitate that is easily visualized under the 
microscope. For every 10mg of DAB, 40 mL of Phosphate Buffer and 17.5 µL of 30% hydrogen 
peroxide was added. Tissue sections sat in DAB solution for 5-15 minutes and allowed to react 
under the microscope. (Figure 2.3) After the precipitate was visualized, the sections were 
washed a final time in 1X PBS for 5 minutes, three times, and carefully mounted on Superfrost 
slides to be stored until further processing.  
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Figure 2.3 Positive DAB staining for BrdU. (A) and (B) Positive DAB staining for BrdU was 
observed under a microscope within the dentate gyrus (DG) of the hippocampus and the 
subventricular zone (SVZ) of the lateral ventricles, respectively. The reaction was visualized by a 
darkening of these regions of interest. (A) shows an example slice of the hippocampus while (B) 
shows staining in the SVZ. Scale bar = 2mm. 
 
 
 
 
 
 
 
 
(A) (B) 
38 
 
Crystal Violet Counter Staining  
 The Crystal Violet stain (Biochemical Sciences, Inc) was used to help to identify the 
morphology of brain sections. Crystal violet binds to Nissl substance, which is found in the soma 
and dendrites of neurons and glial cells. Nissl is composed from the cell’s rough endoplasmic 
reticulum thus can be closely associated with the soma. Axons, on the other band, have little 
Nissl present so therefore appear lighter in color after exposure. Crystal violet assays have been 
demonstrated to help quantify samples based on staining intensity.58 During cell death, a 
typically adherent cell will dissociate from culture and is lost from that sample, thus decreasing 
the amount of crystal violet staining. The overall staining of the tissue created a purple 
backdrop to quantify cells within the regions of interest. After hydrating in distilled water for 3 
minutes, a tray of slides was placed in a 1:100 dilution of Crystal Violet in distilled H2O for 35 
seconds, then immediately placed back in pure diH2O. Next, the tray was placed in two 
separate containers of 75% ethanol for 2 minutes, then placed in 95% ethanol for 3 minutes. 
Following, the tray was moved into two 100% alcohol containers for 3 minutes each. Ethanol 
steps were intended to slowly dehydrate the tissue sections. Then, they were placed in one 
container of Xylene (Citrisolv, Deacon Lab) for 3 minutes, and another container of Xylene for 5 
minutes. Xylene serves the role of a defatting agent. All containers housed a volume of solution 
of 250mL. Finally, coverslips were placed over the slides and sealed using Permount solution.  
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Stereology 
After crystal violet staining was complete, all slides containing regions of the 
hippocampus were analyzed. Five sections, spanning 480 µm, throughout the hippocampus 
were selected for each brain. Sections were observed under an inverted light microscope, 
Olympus DP71, which was paired with the Visiopharm Integrator System (Olympus) program. 
These tools allowed for cell quantification and tissue thickness calculation of the Dentate Gyrus 
(DG). The DG was broken down into the following areas: The Molecular Layer (MOL), the 
Granular Cell Layer (GCL) and the Hilus. Between the GCL and Hilus exists a layer called the 
Subgranular Zone (SGZ), which is a roughly two-cell thick layer, staining prominently with 
crystal violet. Cell bodies are easily identifiable within the region of the SGZ, and extensions of 
the cells typically extend through the GCL to the MOL, as seen experimentally by our lab and 
others 44,59 To start, sections were focused under a 4x objective lens and the outlines were 
made around the DG and Hilus excluding the region of the hippocampus identified as CA3.  
Every positive BrdU cell was counted across the entire height of the optical dissector, using the 
optical fractionator method. The dissector height (h) was set to 15 µm and sections were 
analyzed across that range. Cells outside the height were not included in the total. The total 
number of cells were counted on both the ipsilateral and contralateral side of the tissue of both 
the Granular Zone and Hilus. The values reported for BrdU cells represents the sum of all cells 
for each animal, and the total number of stained cells was calculated to give the estimated 
number of cells throughout the DG of the hippocampus. Using the Optical Fractionator (3D) 
equation n= ΣQ · (t/h)(1/asf)(1/ssf), where the sum Q equals the total number of particles, (t/h) 
is defined as the average section thickness divided by counting frame height, asf represents the 
40 
 
area sampling fraction and was equal to 1, and ssf was valued at 1/8 and represented the 
section sampling fraction. The latter value was determined by calculating the total number of 
sections collected for each brain and assessing that every eighth tissue sample was used in this 
methodology. To determine thickness of the tissue, 5 separate measurements of the focal 
plane of each section were taken. These numbers were averaged to determine the average 
tissue thickness value for each animal.  
Statistical Analysis 
 To determine significance, a one-way ANOVA test was run with the SPSS software. A 
multi-group comparison was complete across the four groups introduced. Included in the 
analysis was a look at the difference in cellular proliferation of the GZ and Hilus, on both the 
ipsilateral and contralateral sides of injury. A Bonferroni test was used with a significant p value 
of less than 0.05.  
 
 
 
 
 
 
 
41 
 
Chapter 3- Results 
 In this study, we focused on the longer-term effects of the Notch signaling in regulating 
survival of proliferating neural stem cells and generation of new neurons in the DG of the 
hippocampus following TBI. In this experiment, we quantified the number of cells representing 
stem cell proliferation/survival (BrdU-positive cells) and neural differentiation (DCX-positive 
cells) at 30 days post-injury across Sham, FPI+Vehicle, FPI+Jagged-1 Fc (Notch1 antagonist), and 
FPI+Notch1 antibody (Notch1 agonist) groups. . All four groups were analyzed to determine the 
difference in proliferation/survival and differentiation within the same region of the brain: the 
dentate gyrus of the hippocampus. For cell counting, the DG (Figure 3.2) was further divided 
into the granular zone (GZ) and the hilus region. An example of a BrdU+ cell, located within the 
subgranular zone of this section, was identified by its circular nucleus and dark color. Figure 3.3 
compares all four animal groups and demonstrates the noticeable difference in proliferation in 
the hippocampus. To analyze our results, we ran a one-way ANOVA multi-group comparison. 
We specifically ran a Bonferroni Post Hoc, comparing mean differences with a 95% confidence 
interval to identify significant differences between groups. Our threshold for significance was 
set to p<0.05.  
 
Determining the longer-term role of Notch1 signaling in survival of proliferated cells following 
TBI.  
To study the effects of activation of Notch signaling on NSCs within the neurogenic 
region of the hippocampus, we used a Notch1 antibody (anti-Notch Extracellular clone 8G10) 
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which acted as an agonist on the Notch1 receptor. Conversely, to assess the effect of Notch 
signaling inhibition on post-TBI neurogenesis, we used human recombinant Jagged-1 Fc, a 
receptor blocking fusion protein.  This fusion protein works to inhibit Notch signaling by binding 
to a ligand of the Notch1 receptor, Jagged1.56 Previous studies have shown that activating 
Notch results in proliferation of stem cells not only in the CNS, but stem cells of non-neural 
origin as well.60,61 More recent work has focused on Notch manipulation by blocking the Notch 
pathway using siRNA against Notch or a ɣ-secretase inhibitor, leading to significantly reduced 
downstream transcriptional effectors. 62 These data, along with our preliminary work, solidified 
our use of these drug treatments. In the current study, animals were infused with 2µg/mL of 
Notch1 or 50 µg/mL of Jagged-1 Fc intraventricularly through an osmotic pump immediately 
following injury for 7 days. As previously demonstrated by our lab, we analyzed completeness 
of injury across the vehicle and drug infusion groups by comparing the righting response time of 
animals post-injury. 20 Righting time (Figure 3.1), among other neurobehavioral measures, were 
measured following lateral FPI to establish a baseline level of injury amongst animal groups.63  
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Figure 3.1 Animal Righting Time Following Injury. The righting time of each animal was 
recorded following LFPI. No significant differences were seen across groups. Error bars = 2x SE. 
 
Analysis of Cellular Proliferation/Survival at 30 DPI 
Intraperitoneal BrdU injections (50mg/kg) were given once daily following injury for 7 
days to timestamp proliferating cells for all groups. Due to its similar structure to the DNA base 
thymine, BrdU is a trusted immunohistochemical tool for labeling proliferating cells. The 
thymine analog incorporates into DNA of dividing cells during S-phase of the cell cycle. 64 As 
BrdU was only available for 2 hours after injection to incorporate into DNA of proliferating cells 
during the 7 days injection period, and since animals were sacrificed at 30 days, the number of 
BrdU-labeled cells in this study represents proliferating cells during the injection period that 
survived at 30 days post-injury.  As shown in Fig. 3.3, BrdU staining was mostly observed in the 
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granular cells layer of the DG.  Intensity of staining represents different stages of division. 
Darker staining represented a more stable state in which BrdU was not diluted due to division, 
whereas lighter staining represented that the cell went through multiple divisions, thus BrdU 
was more diluted.  BrdU+ cells were also observed not only in the subgranular zone where the 
DG neurogenesis occurs, but also into the middle and outer layers of the GZ indicating that 
BrdU-labeled dividing cells migration from the SGZ to the GZ.   
 In counting the total number of BrdU+ cells using unbiased stereology method, we 
found that the number of BrdU+ cells was significantly higher in both the granular zone and 
hilus of the dentate gyrus in animals with Notch1 agonist infusion when compared to Sham 
animals. (Figure 3.4) Specifically, the number of BrdU+ cells in the Notch1 agonist group was 
significantly higher on the contralateral side of GZ (p=0.015) and was trending towards 
significance on the ipsilateral side of injury (p=0.057) when compared to Sham levels. On the 
contralateral GZ, the number of BrdU+ cells were also significantly higher in the Notch1 infused 
group than the Jagged-1 Fc group (p=0.046). In the hilus, the FPI+Notch1 agonist group had a 
significant increase in the number of BrdU+ cells on the ipsilateral side (p=0.001) and 
contralateral side of injury (p=0.000024) versus Sham. In addition, BrdU+ cell in the Notch1 
group was increased significantly against the Jagged-1 Fc antagonist group on the ipsilateral 
(p=0.049) and contralateral (p=0.000216) side of injury within the Hilus. Lastly, comparison of 
the Vehicle group versus Sham demonstrated that injury alone resulted in a significant increase 
on the ipsilateral Hilus (p=0.019) and was trending towards significance contralaterally 
(p=0.055). Collectively, the BrdU data suggested that activation of Notch1 signaling following 
TBI enhances survival of proliferated neural stem cells at the chronic stage when compared to 
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Sham animals following TBI, whereas Notch1 signaling inhibition decreases survival of 
proliferated cells when compared to the Notch agonist group.  
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Figure 3.2 Visualization of BrdU+ staining along the GZ and hilus. In this image, we 
demonstrate what qualified as a positively stained BrdU+ cell. Morphologically, BrdU+ cells 
were identified as the round nucleus of the cells and the darkened color in contrast to 
background staining. BrdU+ cells were typically found along the Subgranular Zone (SGZ) and GZ 
of the DG while fewer were found within the polymorphic layer (hilus). (A) Shows a section at 
4x magnitude, while (B) is shown at 40x.  
 
 
 
(A) 
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Figure 3.3 Visualization of BrdU+ staining across treatment groups. Representative images of 
60µm thick coronal hippocampal tissue sections processed for immunostaining against BrdU 
and counterstained with Crystal Violet Nissl stain. Sections were observed under a 4x lens to 
map the GZ and Hilus of the DG. (A) Sham (B) FPI+Vehicle (C) FPI+Jagged-1 Fc and (D) 
FPI+Notch1. Scale bar = 100 µm. 
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Figure 3.4 Quantification of BrdU positive cells at 30 Days Post-Injury. Proliferation/survival of 
DG neural stem cells was determined by quantifying the number of BrdU+ cells for Sham, 
FPI+Vehicle, FPI+Jagged-1 Fc, and FPI+Notch1 groups at 30 days after TBI. Counts were 
measured on both the ipsilateral and contralateral side of injury in the hilus and granular zone 
(GZ) of the hippocampus using stereological principles. (A) In the GZ, the levels of BrdU+ cells  
in the FPI+Notch1 agonist group was significantly higher in the contralateral side (p=0.015) and 
was trending toward significance in the ipsilateral side (p=0.057) when compared to Sham. The 
number of BrdU+ cells in the FPI+Notch1 group was also significantly higher compared to the 
FPI+Jagged-1 treated group. (B) In the ipsilateral hilus, the number of BrdU+ cells in the 
FPI+Notch1 agonist group was significantly higher compared to Sham (p=0.0001) and 
FPI+Jagged-1 Fc (p=0.049) groups. FPI+Vehicle group had a significantly higher number of BrdU+ 
cells when compared to Sham in the ipsilateral (p=0.019) and contralateral (p=0.011) hilus. In 
the contralateral hilus, the number of BrdU+ cells in the FPI+Notch1 agonist group was also 
significant higher compared to Sham (p=0.000024) and FPI+Jagged-1 Fc (p=0.000216) groups. 
Note that: (*p<0.05, ***p<0.0001) and Error bars set to 2x SE. 
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Analysis of Neural Differentiation 30 DPI 
In addition to examining Notch signaling manipulation on cell proliferation and survival 
within the dentate gyrus of the hippocampus, we also assessed changes in Notch1 signaling in 
the generation of new neurons at the chronic stage following TBI using DCX as the marker. 
Doublecortin X (DCX) was discovered as a microtubule associated protein involved in migration 
of neural progenitor cells (NPC’s). 65 DCX is a marker commonly used to identify the presence of 
immature granule cells and migrating neuroblasts 66–68. In Figure 3.5 (A-D), example sections for 
each group are shown to demonstrate the staining patterns seen in the DG. Typically, dark-
staining regions of cell bodies could be identified around the SGZ of the DG. Less frequently 
would cells be found in the hilus region. Additionally, cells were categorized by morphology of 
their dendrites and identified as vertical, horizontal, or mixed dendrites. This marked their stage 
of maturation stage, with vertical dendrites indicating a more mature stage, as shown in Figure 
3.5 (E-G).  
For quantification, the total number of DCX+ cells regardless of their dendritic 
morphology were lumped together. In both the ipsilateral and contralateral GZ, the number of 
DCX+ cells were slightly higher in the sham and TBI-Vehicle group compared to TBI-Notch1 
agonist and TBI-Notch1 antagonist groups. However, the difference did not reach statistical 
significance. There is no difference in the number of DCX+ cells between the Notch1 agonist 
and antagonist group as well. In the Hilus, the mean value of DCX+ cells for the FPI+Vehicle 
group was higher than the other three groups on both sides of injury but did not reach 
statistical significance in the multi-group comparisons of the one-way ANOVA test. Overall, no 
group difference was found in the GZ and hilus regions across all groups in both ipsilateral and 
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contralateral side of injury (Figure 3.6).  This data suggests that Notch transient signaling 
manipulation does not have prolonged effect on hippocampal neurogenesis.    
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Figure 3.5 Visualization of DCX+ cells in the GZ and Hilus regions. DCX immunostaining was 
carried out in (A) Sham, (B)FPI+Vehicle, (C) FPI+Jagged-1 Fc, and (D) FPI+Notch1 groups. Scale 
bar = 100 µm. Different dendritic morphology was shown: (E) vertical, (F) mixed, or (G) 
horizontal.  The arrows identify corresponding examples of positively stained DCX cells. Scale 
bar = 20 µm. 
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Figure 3.6 Quantification of DCX positive cells at 30 Days Post-Injury. Stereological counts 
were completed to determine the number of DCX+ cells across all four treatment groups. 
Counts were completed across the ipsilateral and contralateral (A) GZ and (B) Hilus for all 
animals. No significant differences were found in the multi-group comparisons. Error bars set to 
2x SE. 
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Chapter 4 – Discussion 
Traumatic brain injury stands as a global health issue affecting millions of people each 
year. In the United States alone, TBI is estimated to have affected over a million people from 
1995 through 2001 according to the CDC. 69 Of that group, 50,000 individuals died from the 
event, while 1.1 million were treated and released. As technology continues to improve, a 
greater number of people will survive TBI-related incidents, therefore creating greater risk of 
post-TBI complications over time. It is our hope that increasing the understanding of how TBI 
affects the brain will allow for immediate, efficient treatment to limit, or perhaps even prevent, 
the outstanding secondary injuries commonly associated with this injury model.   
In this dissertation, we have discussed a very brief overview of the study of 
neurogenesis, the Notch signaling pathway, TBI, and how all three of those are intertwined. 
Neurogenesis is a crucial process during homeostatic and pathological conditions. Notch 
signaling, one of the key mechanisms in regulating neurogenesis, plays a vital role in normal 
development of the brain 70 and maintenance in later stages of adulthood.48 Specifically, the 
Notch1 signaling pathway plays a role in proliferation, differentiation, and apoptosis of NSCs in 
direct association with specific cellular signals. Our lab has explored  the role of Notch signaling 
in regulating the regenerative neural stem cell response following TBI. 20,44,71 Thus far, we have 
analyzed the short-term effects of Notch manipulation; this study questioned the long-term 
effects of Notch manipulation in the neurogenic niches of the brain during the chronic stage 
following TBI to gain insight on how post-injury regenerative stem cells are affected by Notch 
signaling.  
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Summary of Results 
In this study, we analyzed the significance of the Notch signaling pathway manipulation 
in adult neurogenesis following TBI.  Notch pathway manipulation was achieved by 
intraventricular infusion of Notch1 inhibitor Jagged-1 Fc or Notch1 activator Notch1 antibody 
for 7 days immediately following a lateral fluid percussive injury.  Animals were sacrificed at 30 
days post-injury.  The number of BrdU-positive cells that were labeled via intraperitoneal BrdU 
injection during the infusion period was utilized as the indicator of Notch manipulation on 
neural stem cell proliferation and survival, whereas immature neuronal marker DCX was used 
as the indicator of generation of new neurons. We found that at 30 days post-injury, the 
FPI+Notch1 agonist group had a significant increase in survival of proliferated cells, as 
measured with BrdU+ cell quantification, when compared to Sham groups in both the granular 
zone (GZ) and hilus region of the dentate gyrus (DG) in the hippocampus. The FPI+Notch1 group 
also had significantly higher number of BrdU+ cells compared to FPI+Jagged-1 Fc group on both 
the ipsilateral and contralateral Hilus, as well as the contralateral GZ. In addition, there was a 
significant increase in proliferation in FPI+Vehicle versus Sham groups throughout the Hilus.   
In the assessment of DCX+ cells, we found that no significant differences were 
established when comparing Sham, FPI+Vehicle, FPI+Jagged-1 Fc, and FPI+Notch1 groups. 
Within the ipsilateral GZ, Sham and FPI+Vehicle maintained roughly the same mean values of 
DCX+ cells, although both FPI+Jagged-1 Fc and FPI+Notch1 had a tendency for a slightly lower 
mean value in this region. On the contralateral side of injury, elevated levels of DCX+ cells were 
seen in the FPI+Vehicle group when compared against other groups in the GZ of the 
hippocampus. FPI+Notch1 maintained a lower value of doublecortin-positive cells throughout 
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the GZ. In the hilus, DCX+ cells were highest in the FPI+Vehicle group on both the ipsilateral and 
contralateral side of injury. There was a tendency for a slight increase in DCX-positive cells for 
both the FPI+Notch1 and FPI+Jagged-1 Fc groups when compared to sham in the ipsilateral 
hilus as well, but no corresponding trend on the contralateral side of injury.  
 
Cellular Proliferation at 30 DPI 
 In a previous experiment carried out in our lab, cellular proliferation following TBI was 
analyzed at 7 DPI in the GZ and hilus regions of the hippocampus. Comparatively, in the current 
study we set out to determine the longer-term effects of Notch signaling following TBI at 30 
DPI. This experiment helped further the understanding what happens in the DG following 
traumatic brain injury and what effect manipulation of the Notch signaling pathway has on 
cellular proliferation at 30 DPI.  
Pharmacological manipulation to upregulate the Notch1 signaling pathway was directly 
responsible for increased cell proliferation in the hippocampus. In the current study, a 
significant increase in the number of BrdU+ cells was observed in the GZ and the hilus region of 
the contralateral side of injury, and close to significant increase in the GZ of the ipsilateral side 
of GZ (p=0.057) in animals that received Notch1 activator treatment compared to Sham and 
injured animals with Notch1 inhibitor treatment. Additionally, the FPI+Vehicle group had a 
significant increase of positive BrdU cells when compared to Sham animals. These data suggest 
that injury alone was enough to cause a significant increase in cellular proliferation/survival in 
the DG of animals, which is in agreement with our previous observation.72 Our data also suggest 
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that activation of the Notch1 pathway on top of injury does not provide further enhancement 
of cell proliferation/survival as no difference was observed between injured vehicle group and 
Notch1 activator group. Our previous study found that TBI can enhance Notch pathway 
activation by upregulation of the Notch1 pathway protein expression levels during the acute 
post-injury stage. At this timepoint, Notch ligand and receptor binding may have already 
reached maximal efficiency, thus supplementation with exogenous Notch1 activator does not 
have any additional effect.  However, in this study, inhibition of the Notch pathway using 
Jagged-1 Fc prevented the proliferative response, suggesting that Notch signaling is uniquely 
involved in the endogenous proliferative response.  
 
Neural Generation at 30 DPI 
Identification of doublecortin-positive cells has served as an important tool for 
observing adult neurogenesis in mammals. 73 DCX is a known microtubule associated protein 
that stabilizes the cellular skeleton of immature and migrating neurons. 65 In analyzing neural 
differentiation of our tissue, we ran the sections through a series of immunological steps using 
an antibody against DCX to mark newly generated neurons. 
In this experiment, we observed slightly higher number of DCX-positive cells in 
FPI+Vehicle when compared to Sham animals. Interestingly, we saw a relative decrease in DCX-
positive cells in both the FPI+Notch1 and FPI+Jagged-1 groups. In part, these finding remain 
consistent with what we anticipated to be true; for our FPI+Notch1 agonist group, higher levels 
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of proliferation were expected to result in a relative inhibition of levels of differentiation. We 
observed this trend throughout the granular zone and in portions of the hilus.  
This trend corresponds with what we know about Notch activation and what previous 
studies have demonstrated as well. Upregulation of the Notch pathway should result in 
increased negative transcription regulators like Hes genes, which are known to antagonize pro-
neural genes, thus preventing differentiation.46 Other studies demonstrated that inhibition of 
the Notch pathway in stem cells, both in vivo and in vitro, resulted in accelerated neural 
differentiation.74 DCX is a widely used marker for detecting of newly generated neurons during 
the 2-week period following generation. As the Notch1 activator and inhibitor were 
administrated only for the first 7 days post-injury, whereas the animals were sacrificed at 30 
days post-injury, DCX+ cells that we observed were new neurons generated around 15-30 days 
post-injury, well after the termination of Notch1 manipulation. Our data suggested that short-
term modulation of Notch1 signaling with pharmacological agents does not have prolonged 
effect on neurogenesis. Our data showed the trend of a lower number of DCX+ cells in the GZ 
and hilus region in animals that received Notch manipulation compared to Sham and injury-
Vehicle groups. That the statistical difference is not significant is possibly due to the big 
variable. Increasing animal number for each group may reduce the variable and provide more 
accurate information.     
Our data allows us to further understand how TBI affects the neurogenic regions of the 
brain. Upregulation of the Notch1 signaling pathway resulted in an overall increase in survival 
of proliferated cells in response to injury when compared to Sham animals; however, what is 
not yet understood is the outcome of these proliferated cells. Further studies using double-
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labeling techniques, examining the fate of differentiation of the BrdU-labeled cells with 
different cell markers, such as mature neuronal marker, astrocytes, and other glial cell markers 
as well as neural stem cell markers will answer this question.    
 
Conclusion and Future Direction 
 Much has been done to understand, prevent, and treat TBI over the last few decades, 
but much work remains. In this study, we have analyzed a portion of the long-term role that the 
Notch signaling pathway plays in regulating endogenous neurogenesis in the adult brain 
following TBI.  We found that upregulation of Notch signaling, through intraventricular infusion 
of Notch1 antibody, causes a significant increase in cell proliferation/survival at 30 DPI in the 
DG of the hippocampus. While significant cellular proliferation was observed in the DG, 
upregulation of the Notch pathway at the acute stage post-injury does not have prolonged 
effect in generation of new neurons during the chronic stage following injury. As the current 
study lacks examination of the fate mapping of Notch1 activation-induced proliferated cells, 
also taking into consideration the relative low number of animals included in this study, the 
results of the current study are not conclusive. In order to solidify our understanding of what 
occurred, increasing animal numbers across groups could allow for greater clarity. Additionally, 
further experimentation using double-labeling to determine quantity of mature neurons (using 
NeuN) or astrocyte proliferation (with GFAP) could help expose wherein lies the difference in 
cell type. 
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